fashion -WSS

fashion

author：explore 2025-09-30 11:58:19 - browse：9

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of expert advisers to the Food and Drug Administration on Friday voted in favor of expanding the use of CAR-T therapy in blood cancer, despite concerns about the powerful treatment’s side effects.

The group voted 11-0 that the benefits of Carvykti, a CAR-T medicine from Johnson & Johnson and Legend Biotech, outweighed its risk for patients with multiple myeloma whose disease has persisted despite initial treatment. The same panel voted 8-3 in favor of Abecma, from Bristol Myers Squibb and 2seventy Bio, for multiple myeloma patients who’ve received at least two lines of therapy. Currently both medicines are approved only for patients who have been treated for myeloma with four or more medications.

In clinical trials, each drug proved to significantly delay disease progression compared to standard therapy. But zooming in on the data, the FDA observed an alarming imbalance of deaths in the early months of both studies, finding that more patients in the CAR-T group died of myeloma or side effects than those receiving the standard of care.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Why Novartis is changing the name of its research labs

hotspot

WSS

House transparency, PBM reform bill gains bipartisan support

Maui funeral service workers on devastation of fires: 'I'm in shock'

House transparency, PBM reform bill gains bipartisan support

How generative AI is inspiring dreams of a health data revolution

Target recalls 2.2 million additional candles due to laceration, burn hazards

An innovative path out of biotech’s “valley of death”

entertainment

fashion

focus

Duchenne breakthrough therapy leaves behind pioneering families

How to protect patients from sexual assault

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Some of the ways extreme heat will change life as we know it

At least 13 dead in Texas as scorching temps continue

Medicaid rebukes states for mistakenly disenrolling children

New air purifier tech could be key to improving indoor air quality

CDC overhauls leadership of center that led response to Covid

Sports medicine is finally prioritizing gender equality

Amazon on where the company's health care bets are headed next

focus

Maui funeral service workers on devastation of fires: 'I'm in shock'

Weighted lottery helped low

House transparency, PBM reform bill gains bipartisan support

Novo acquires Inversago for up to $1 billion

NIH nominee Bertagnolli will get October confirmation hearing

The 10 drugs up first for Medicare price negotiation

leisure time

Wikipedia

hotspot

focus